Cell Medicines R&D Co-op: Cancer Immunotherapy
Listed on 2026-10-15
-
Healthcare
Medical Science, Clinical Research, Oncology Care -
Research/Development
Medical Science, Clinical Research, Immunology Research, Oncology Care
Regeneron Pharmaceuticals in Cambridge, MA (with Seattle, WA) is seeking multiple 2027 Co-ops to join the Regeneron Cell Medicines team, developing next-generation T-cell therapies for cancer. These full-time, on-site positions run January–August, May–December, or August–December.
Pay ranges depend on education level and program, with hourly rates from $17.90 to $50.90. Candidates should be enrolled in an Undergraduate or Graduate program and commit to 40 hours per week.
Are you ready to take on the Cell Medicines R&D Co-op:
Cancer Immunotherapy role at Regeneron Pharmaceuticals?
This role, Cell Medicines R&D Co-op:
Cancer Immunotherapy at Regeneron Pharmaceuticals, could be your next career step.
We would love to welcome a new Cell Medicines R&D Co-op:
Cancer Immunotherapy to our team in Cambridge, MA, United States.
For the Cell Medicines R&D Co-op:
Cancer Immunotherapy position at Regeneron Pharmaceuticals, we are reviewing applications now.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).